Anti-MOG-associated demyelinating disorders: two sides of the same coin.
Giorgia Teresa ManiscalcoLia AllegoricoGennaro AlfieriMassimo NapolitanoAngelo RanieriRosaria RennaGiovanna ServilloMarianna PezzellaElisa CaponeLidia AltomareMichele SpinielloSergio FerrariValentino ManzoSara MariottoPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
MOGAD is an extremely variable disease which can relapse and accumulate disability over time. An early diagnosis and correct timely treatment is fundamental to improve clinical outcome.